Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 15761-15770 Newer>

The Motley Fool July 25, 2006 Stephen D. Simpson	Freeport-McMoRan's Risky Business One mine, two commodities, and a spike in prices. How will this end up? Investors, be sure to do some careful due diligence before diving in.
The Motley Fool July 25, 2006 Ryan Fuhrmann	A Steady Heartbeat at Edwards Can Edwards Lifesciences grow enough to justify its stock price?
The Motley Fool July 25, 2006 Anders Bylund	Foolish Forecast: Buffalo Wild Wings The restaurant is reporting earnings tonight, and investors are watching. The company has been a steady performer and an exciting growth story over the last couple of years. Can it keep it up?
The Motley Fool July 25, 2006 Stephen D. Simpson	Rent-A-Center Finds the Fuel for Growth Apart from the gibbering about fuel, there are real signs of progress here. Investors would be wise to keep a sharp eye on this company.
The Motley Fool July 25, 2006 Ryan Fuhrmann	Bill Miller, Money Master: Part 2 Part 2 of a five-article write-up regarding legendary investor Bill Miller. Does he believe in any form of the efficient market hypothesis?... Best, worst, current stock picks... etc.
The Motley Fool July 25, 2006 Stephen D. Simpson	Can BP Do Better? Unless BP can correct a series of mistakes, there's no reason to favor this major producer. Investors, take note.
The Motley Fool July 25, 2006 Dan Bloom	Texas Instruments Keeps Growing Its technology changes with the times, helping it turn in another fine quarter. If the economy does struggle, Texas Instruments is one stock investors should look to buy on a weakness.
The Motley Fool July 25, 2006 Tim Beyers	Limelight Takes the Spotlight Will this upstart grow up to kill Akamai? Or is there room for both content networks for digital media? Investors, take note.
The Motley Fool July 25, 2006 Alex Dumortier	AMVESCAP Goes Alternative A big deal for private equity: UK asset management firm AMVESCAP PLC agreed to purchase restructuring specialist WL Ross & Co., in a deal that could ultimately be worth $375 million over the next five years. Investors, take note.
The Motley Fool July 25, 2006 Brian Lawler	Strike Two for Encysive The FDA still won't quite give Thelin a thumbs-up. For now, Encysive investors can only sit and wait.
<Older 15761-15770 Newer> Return to current articles.